Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...

Parkinson Disease ll: Pathophysiology

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Disruption of the brain-spleen axis impairs monocyte-microglia communication and accelerates disease progression in a mouse model of amyloidosis.

Nature communications·2026

Same author

Retinitis pigmentosa: Diagnosis and management.

Handbook of clinical neurology·2026

Same author

A human subcortical connectome at 400 μm resolution.

bioRxiv : the preprint server for biology·2026

Same author

Multi-dimensional diffusion MRI at ultra-high gradient strength for mapping axonal architecture and microstructure in the primate brain.

bioRxiv : the preprint server for biology·2026

Same author

Sleep circuit modulation: from animal models to human translation.

Brain : a journal of neurology·2026

Same author

Medial prefrontal-thalamic white matter microstructure is associated with harm avoidance in OCD: a discovery and transdiagnostic replication study.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2026

Search research articles

Related Experiment Video

Updated: May 28, 2026

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Published on: July 16, 2014

Closed-loop deep brain stimulation is superior in ameliorating parkinsonism.

Boris Rosin¹, Maya Slovik, Rea Mitelman

¹Department of Medical Neurobiology (Physiology), The Institute for Medical Research Israel-Canada, The Hebrew University-Hadassah Medical Association School of Medicine and Hadassah University Hospital, Jerusalem 91120, Israel. boris.rosin@mail.huji.ac.il

|October 25, 2011

Summary

Closed-loop deep brain stimulation (DBS) offers a novel approach for Parkinson's disease (PD) by targeting abnormal brain rhythms. This strategy shows greater efficacy than traditional DBS in a primate model, potentially improving PD management.

More Related Videos

Closed-Loop Neurostimulation for Biomarker-Driven, Personalized Treatment of Major Depressive Disorder

Closed-Loop Neurostimulation for Biomarker-Driven, Personalized Treatment of Major Depressive Disorder

Published on: July 7, 2023

A Novel Approach to Assess Motor Outcome of Deep Brain Stimulation Effects in the Hemiparkinsonian Rat: Staircase and Cylinder Test

A Novel Approach to Assess Motor Outcome of Deep Brain Stimulation Effects in the Hemiparkinsonian Rat: Staircase and Cylinder Test

Published on: May 31, 2016

Related Experiment Videos

Last Updated: May 28, 2026

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Published on: July 16, 2014

Closed-Loop Neurostimulation for Biomarker-Driven, Personalized Treatment of Major Depressive Disorder

Closed-Loop Neurostimulation for Biomarker-Driven, Personalized Treatment of Major Depressive Disorder

Published on: July 7, 2023

A Novel Approach to Assess Motor Outcome of Deep Brain Stimulation Effects in the Hemiparkinsonian Rat: Staircase and Cylinder Test

A Novel Approach to Assess Motor Outcome of Deep Brain Stimulation Effects in the Hemiparkinsonian Rat: Staircase and Cylinder Test

Published on: May 31, 2016

Area of Science:

Neuroscience
Neurology
Biomedical Engineering

Background:

Deep brain stimulation (DBS) is a common therapy for advanced Parkinson's disease (PD).
The precise mechanisms by which DBS alleviates PD symptoms are not fully understood.
Current DBS techniques primarily focus on continuous stimulation, with ongoing debate regarding their optimal application.

Purpose of the Study:

To investigate a closed-loop stimulation strategy for PD management.
To explore the effects of closed-loop DBS on basal ganglia (BG) activity and PD symptoms in a primate model.
To compare the efficacy of closed-loop DBS with standard open-loop DBS and control paradigms.

Main Methods:

Utilized the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) primate model of PD.
Applied pallidal and cortico-pallidal closed-loop stimulation strategies.
Analyzed changes in BG discharge rates and patterns, as well as motor symptoms like akinesia.
Compared closed-loop DBS with open-loop DBS and control stimulation.

Main Results:

Closed-loop pallidal stimulation demonstrated a dissociation between BG discharge rates and patterns.
Cortico-pallidal closed-loop DBS significantly improved akinesia compared to open-loop DBS and control.
Closed-loop stimulation effectively modulated pathological oscillatory activity in the BG-cortical networks.

Conclusions:

Closed-loop DBS, by targeting pathological brain rhythms, may offer a more effective approach to managing advanced Parkinson's disease.
This strategy has the potential to be beneficial for other neurological disorders characterized by abnormal neuronal discharge patterns.
Modulating oscillatory activity, rather than just discharge rate, is key to the therapeutic effects of closed-loop DBS in PD.